Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,490 | -60,133 | -36,773 | -16,028 | -60,058 |
| Depreciation Amortization | 1,650 | 1,100 | 501 | 507 | 507 |
| Accounts receivable | 427 | 791 | 760 | -895 | 490 |
| Accounts payable and accrued liabilities | 333 | 924 | 509 | -473 | 502 |
| Other Working Capital | 3,295 | 5,244 | 2,274 | -1,299 | 912 |
| Other Operating Activity | 16,958 | 10,071 | 6,109 | 4,252 | 9,579 |
| Operating Cash Flow | $-66,827 | $-42,003 | $-26,620 | $-13,936 | $-48,068 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,823 | 3,726 | 1,029 | 10,808 | -25,085 |
| PPE Investments | -1,258 | -936 | -621 | -364 | -1,624 |
| Investing Cash Flow | $25,565 | $2,790 | $408 | $10,444 | $-26,709 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 99,600 | 34,600 | 34,600 | N/A | N/A |
| Common Stock Issued | 9,110 | 3,192 | 1,201 | 675 | 64,788 |
| Other Financing Activity | 133 | -193 | 294 | 0 | 620 |
| Financing Cash Flow | $108,843 | $37,599 | $36,095 | $675 | $65,408 |
| Beginning Cash Position | 23,735 | 23,735 | 23,735 | 23,735 | 33,104 |
| End Cash Position | 91,316 | 22,121 | 33,618 | 20,918 | 23,735 |
| Net Cash Flow | $67,581 | $-1,614 | $9,883 | $-2,817 | $-9,369 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,827 | -42,003 | -26,620 | -13,936 | -48,068 |
| Capital Expenditure | -1,258 | -936 | -621 | -364 | -1,624 |
| Free Cash Flow | -68,085 | -42,939 | -27,241 | -14,300 | -49,692 |